Replies to post #163206 on Biotech Values

[DewDiligence]

ENTA/Medivir—Is there enough hard data on the efficacy of ABT-450 in combination with PegRiba? If so which drug (in your opinion) appears superior?

ABT-450 has not been tested much with interferon, although there will some data trickling out during the next few years from second-line studies in patients who failed on Incivek- or ABT-450-based regimens. In any event, how ABT-450 + IFN performs relative to Simprevir + IFN would not seem to be a major concern for ABBV and ENTA investors.